Nucleic Acid Therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
518
NCT06317350
Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 11, 2024
Completion: Oct 16, 2024
NCT06743035
Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
Phase: N/A
Role: Collaborator
Start: Dec 3, 2024
Completion: Jul 31, 2029
Loading map...